SARS-CoV Spike anticorps (N-Term)
Aperçu rapide pour SARS-CoV Spike anticorps (N-Term) (ABIN7795016)
Antigène
Voir toutes SARS-CoV Spike (SARS-CoV S) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- Anti-SARS-CoV Spike (NT)
-
Specificité
- Rabbit Anti-Severe Acute Respiratory Syndrome Spike (SARS Spike) recognizes an epitope near the N-terminus of SARS Spike. This polyclonal antibody was purified using affinity chromatography. Background A coronavirus, SARS (Severe Acute Respiratory Syndrome), was first identified 2002-2003. Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately in length. SARS can be mediated by the binding of the viral spike protein, a glycosylated protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 μg/mL
-
Buffer
- This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02 % sodium azide as a preservative.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
-
-
- SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))
-
Autre désignation
- SARS-CoV Spike
-
Classe de substances
- Viral Protein
Antigène
-